J&J consumer boss retires as Tylenol probe widens

NEW YORK (Reuters) – Johnson & Johnson announced the retirement of its longtime head of consumer products on Thursday, hours after a U.S. congressional panel disclosed new potentially damaging information about J&J's recent recalls of Tylenol and other consumer medicines. The diversified healthcare company said Colleen Goggins, 56, who has headed its McNeil consumer healthcare group for more than a decade, would retire effective March 1 and it would name her successor at a later date.